Vaccinia virus as a vaccine delivery system for marsupial wildlife

Abstract Vaccines based on recombinant poxviruses have proved successful in controlling diseases such as rabies and plague in wild eutherian mammals. They have also been trialled experimentally as delivery agents for fertility-control vaccines in rodents and foxes. In some countries, marsupial mamma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2011-06, Vol.29 (28), p.4537-4543
Hauptverfasser: Cross, Martin L, Fleming, Stephen B, Cowan, Phil E, Scobie, Susie, Whelan, Ellena, Prada, Diana, Mercer, Andrew A, Duckworth, Janine A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4543
container_issue 28
container_start_page 4537
container_title Vaccine
container_volume 29
creator Cross, Martin L
Fleming, Stephen B
Cowan, Phil E
Scobie, Susie
Whelan, Ellena
Prada, Diana
Mercer, Andrew A
Duckworth, Janine A
description Abstract Vaccines based on recombinant poxviruses have proved successful in controlling diseases such as rabies and plague in wild eutherian mammals. They have also been trialled experimentally as delivery agents for fertility-control vaccines in rodents and foxes. In some countries, marsupial mammals represent a wildlife disease reservoir or a threat to conservation values but, as yet there has been no bespoke study of efficacy or immunogenicity of a poxvirus-based vaccine delivery system in a marsupial. Here, we report a study of the potential for vaccination using vaccinia virus in the Australian brushtail possum Trichosurus vulpecula , an introduced pest species in New Zealand. Parent-strain vaccinia virus (Lister) infected 8/8 possums following delivery of virus to the oral cavity and outer nares surfaces (oronasal immunisation), and persisted in the mucosal epithelium around the palatine tonsils for up to 2 weeks post-exposure. A recombinant vaccinia virus construct (VV399, which expresses the Eg95 antigen of the hydatid disease parasite Echinococcus granulosus ) was shown to infect 10/15 possums after a single-dose oronasal delivery and to also persist. Both parent vaccinia virus and the VV399 construct virus induced peripheral blood lymphocyte reactivity against viral antigens in possums, first apparent at 4 weeks post-exposure and still detectable at 4 months post-exposure. Serum antibody reactivity to Eg95 was recorded in 7/8 possums which received a single dose of the VV399 construct and 7/7 animals which received triple-dose delivery, with titre end-points in the latter case exceeding 1/4000 dilution. This study demonstrates that vaccinia virus will readily infect possums via a delivery means used to deploy wildlife vaccines, and in doing is capable of generating immune reactivity against viral and heterologous antigens. This highlights the future potential of recombinant vaccinia virus as a vaccine delivery system in marsupial wildlife.
doi_str_mv 10.1016/j.vaccine.2011.04.093
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_874194191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X11006487</els_id><sourcerecordid>874194191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-4a23910a8886f605ad4dc134f61a689129fece5a7a1ec9904041e17353ab3d103</originalsourceid><addsrcrecordid>eNqNkk2L1EAQhhtxccfVn6AERDwlVvVX0hcXXdRdWPDgB96a3k4FeswkY_dkZP69HSe6sBcXCury1Ntd71uMPUOoEFC_Xld7530YqOKAWIGswIgHbIVNLUqusHnIVsC1LCXC91P2OKU1ACiB5hE75ahqkEKt2Ltvf1SCK_YhTqlwuYpFuWipD3uKhyId0o42RTfGYuNimrbB9cWv0Ld96OgJO-lcn-jp0s_Y1w_vv1xcltefPl5dvL0uvQKzK6XjwiC4pml0p0G5VrYehew0Ot0Y5KYjT8rVDskbAxIkEtZCCXcjWgRxxl4ddbdx_DlR2tlNSJ763g00Tsk2tUSTC-9BcsWV4bPmizvkepzikNewqLExstYwU-pI-TimFKmz2xiyEQeLYOc07Nountk5DQvS5jTy3PNFfbrZUPtv6q_9GXi5AC5513fRDT6kW07yhqPUmTs_cpT93QeKNvlAg6c2RPI7247hv195c0fB9zn2_OgPOlC63dombsF-nk9nvhxEAC3zTf0GUEK9Jg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1618947600</pqid></control><display><type>article</type><title>Vaccinia virus as a vaccine delivery system for marsupial wildlife</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Cross, Martin L ; Fleming, Stephen B ; Cowan, Phil E ; Scobie, Susie ; Whelan, Ellena ; Prada, Diana ; Mercer, Andrew A ; Duckworth, Janine A</creator><creatorcontrib>Cross, Martin L ; Fleming, Stephen B ; Cowan, Phil E ; Scobie, Susie ; Whelan, Ellena ; Prada, Diana ; Mercer, Andrew A ; Duckworth, Janine A</creatorcontrib><description>Abstract Vaccines based on recombinant poxviruses have proved successful in controlling diseases such as rabies and plague in wild eutherian mammals. They have also been trialled experimentally as delivery agents for fertility-control vaccines in rodents and foxes. In some countries, marsupial mammals represent a wildlife disease reservoir or a threat to conservation values but, as yet there has been no bespoke study of efficacy or immunogenicity of a poxvirus-based vaccine delivery system in a marsupial. Here, we report a study of the potential for vaccination using vaccinia virus in the Australian brushtail possum Trichosurus vulpecula , an introduced pest species in New Zealand. Parent-strain vaccinia virus (Lister) infected 8/8 possums following delivery of virus to the oral cavity and outer nares surfaces (oronasal immunisation), and persisted in the mucosal epithelium around the palatine tonsils for up to 2 weeks post-exposure. A recombinant vaccinia virus construct (VV399, which expresses the Eg95 antigen of the hydatid disease parasite Echinococcus granulosus ) was shown to infect 10/15 possums after a single-dose oronasal delivery and to also persist. Both parent vaccinia virus and the VV399 construct virus induced peripheral blood lymphocyte reactivity against viral antigens in possums, first apparent at 4 weeks post-exposure and still detectable at 4 months post-exposure. Serum antibody reactivity to Eg95 was recorded in 7/8 possums which received a single dose of the VV399 construct and 7/7 animals which received triple-dose delivery, with titre end-points in the latter case exceeding 1/4000 dilution. This study demonstrates that vaccinia virus will readily infect possums via a delivery means used to deploy wildlife vaccines, and in doing is capable of generating immune reactivity against viral and heterologous antigens. This highlights the future potential of recombinant vaccinia virus as a vaccine delivery system in marsupial wildlife.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2011.04.093</identifier><identifier>PMID: 21570435</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Administration, Oral ; Allergy and Immunology ; Animal reproduction ; Animals ; Animals, Wild - virology ; Antibodies, Helminth - blood ; Antigens ; Antigens, Helminth - genetics ; Antigens, Helminth - immunology ; Antigens, Helminth - metabolism ; Applied microbiology ; Biological and medical sciences ; Disease ; Disease control ; Diseases caused by cestodes ; Drug Delivery Systems - methods ; Drug Delivery Systems - veterinary ; Echinococcoses ; Echinococcosis - immunology ; Echinococcosis - prevention &amp; control ; Echinococcus granulosus ; Echinococcus granulosus - genetics ; Echinococcus granulosus - immunology ; Echinococcus granulosus - metabolism ; Female ; Fertility ; Fertility-control ; Fundamental and applied biological sciences. Psychology ; Genetic Vectors ; Helminth Proteins - genetics ; Helminth Proteins - immunology ; Helminth Proteins - metabolism ; Helminthic diseases ; Hydatid disease ; Immunization ; Immunogenicity ; Infections ; Infectious diseases ; Introduced species ; Livestock ; Lymphocyte Activation ; Lymphocytes ; Mammals ; Marsupial ; Marsupials ; Medical sciences ; Microbiology ; Miscellaneous ; Oronasal vaccine ; Parasitic diseases ; Poxvirus ; Reproductive system ; Trichosurus - virology ; Trichosurus vulpecula ; Vaccines ; Vaccines - administration &amp; dosage ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Vaccinia ; Vaccinia virus ; Vaccinia virus - genetics ; Vaccinia virus - immunology ; Vaccinia virus - pathogenicity ; Virology ; Wildlife</subject><ispartof>Vaccine, 2011-06, Vol.29 (28), p.4537-4543</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Jun 20, 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c509t-4a23910a8886f605ad4dc134f61a689129fece5a7a1ec9904041e17353ab3d103</citedby><cites>FETCH-LOGICAL-c509t-4a23910a8886f605ad4dc134f61a689129fece5a7a1ec9904041e17353ab3d103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1618947600?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,64361,64363,64365,65309,72215</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24282146$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21570435$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cross, Martin L</creatorcontrib><creatorcontrib>Fleming, Stephen B</creatorcontrib><creatorcontrib>Cowan, Phil E</creatorcontrib><creatorcontrib>Scobie, Susie</creatorcontrib><creatorcontrib>Whelan, Ellena</creatorcontrib><creatorcontrib>Prada, Diana</creatorcontrib><creatorcontrib>Mercer, Andrew A</creatorcontrib><creatorcontrib>Duckworth, Janine A</creatorcontrib><title>Vaccinia virus as a vaccine delivery system for marsupial wildlife</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract Vaccines based on recombinant poxviruses have proved successful in controlling diseases such as rabies and plague in wild eutherian mammals. They have also been trialled experimentally as delivery agents for fertility-control vaccines in rodents and foxes. In some countries, marsupial mammals represent a wildlife disease reservoir or a threat to conservation values but, as yet there has been no bespoke study of efficacy or immunogenicity of a poxvirus-based vaccine delivery system in a marsupial. Here, we report a study of the potential for vaccination using vaccinia virus in the Australian brushtail possum Trichosurus vulpecula , an introduced pest species in New Zealand. Parent-strain vaccinia virus (Lister) infected 8/8 possums following delivery of virus to the oral cavity and outer nares surfaces (oronasal immunisation), and persisted in the mucosal epithelium around the palatine tonsils for up to 2 weeks post-exposure. A recombinant vaccinia virus construct (VV399, which expresses the Eg95 antigen of the hydatid disease parasite Echinococcus granulosus ) was shown to infect 10/15 possums after a single-dose oronasal delivery and to also persist. Both parent vaccinia virus and the VV399 construct virus induced peripheral blood lymphocyte reactivity against viral antigens in possums, first apparent at 4 weeks post-exposure and still detectable at 4 months post-exposure. Serum antibody reactivity to Eg95 was recorded in 7/8 possums which received a single dose of the VV399 construct and 7/7 animals which received triple-dose delivery, with titre end-points in the latter case exceeding 1/4000 dilution. This study demonstrates that vaccinia virus will readily infect possums via a delivery means used to deploy wildlife vaccines, and in doing is capable of generating immune reactivity against viral and heterologous antigens. This highlights the future potential of recombinant vaccinia virus as a vaccine delivery system in marsupial wildlife.</description><subject>Administration, Oral</subject><subject>Allergy and Immunology</subject><subject>Animal reproduction</subject><subject>Animals</subject><subject>Animals, Wild - virology</subject><subject>Antibodies, Helminth - blood</subject><subject>Antigens</subject><subject>Antigens, Helminth - genetics</subject><subject>Antigens, Helminth - immunology</subject><subject>Antigens, Helminth - metabolism</subject><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Disease</subject><subject>Disease control</subject><subject>Diseases caused by cestodes</subject><subject>Drug Delivery Systems - methods</subject><subject>Drug Delivery Systems - veterinary</subject><subject>Echinococcoses</subject><subject>Echinococcosis - immunology</subject><subject>Echinococcosis - prevention &amp; control</subject><subject>Echinococcus granulosus</subject><subject>Echinococcus granulosus - genetics</subject><subject>Echinococcus granulosus - immunology</subject><subject>Echinococcus granulosus - metabolism</subject><subject>Female</subject><subject>Fertility</subject><subject>Fertility-control</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic Vectors</subject><subject>Helminth Proteins - genetics</subject><subject>Helminth Proteins - immunology</subject><subject>Helminth Proteins - metabolism</subject><subject>Helminthic diseases</subject><subject>Hydatid disease</subject><subject>Immunization</subject><subject>Immunogenicity</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Introduced species</subject><subject>Livestock</subject><subject>Lymphocyte Activation</subject><subject>Lymphocytes</subject><subject>Mammals</subject><subject>Marsupial</subject><subject>Marsupials</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Oronasal vaccine</subject><subject>Parasitic diseases</subject><subject>Poxvirus</subject><subject>Reproductive system</subject><subject>Trichosurus - virology</subject><subject>Trichosurus vulpecula</subject><subject>Vaccines</subject><subject>Vaccines - administration &amp; dosage</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Vaccinia</subject><subject>Vaccinia virus</subject><subject>Vaccinia virus - genetics</subject><subject>Vaccinia virus - immunology</subject><subject>Vaccinia virus - pathogenicity</subject><subject>Virology</subject><subject>Wildlife</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkk2L1EAQhhtxccfVn6AERDwlVvVX0hcXXdRdWPDgB96a3k4FeswkY_dkZP69HSe6sBcXCury1Ntd71uMPUOoEFC_Xld7530YqOKAWIGswIgHbIVNLUqusHnIVsC1LCXC91P2OKU1ACiB5hE75ahqkEKt2Ltvf1SCK_YhTqlwuYpFuWipD3uKhyId0o42RTfGYuNimrbB9cWv0Ld96OgJO-lcn-jp0s_Y1w_vv1xcltefPl5dvL0uvQKzK6XjwiC4pml0p0G5VrYehew0Ot0Y5KYjT8rVDskbAxIkEtZCCXcjWgRxxl4ddbdx_DlR2tlNSJ763g00Tsk2tUSTC-9BcsWV4bPmizvkepzikNewqLExstYwU-pI-TimFKmz2xiyEQeLYOc07Nountk5DQvS5jTy3PNFfbrZUPtv6q_9GXi5AC5513fRDT6kW07yhqPUmTs_cpT93QeKNvlAg6c2RPI7247hv195c0fB9zn2_OgPOlC63dombsF-nk9nvhxEAC3zTf0GUEK9Jg</recordid><startdate>20110620</startdate><enddate>20110620</enddate><creator>Cross, Martin L</creator><creator>Fleming, Stephen B</creator><creator>Cowan, Phil E</creator><creator>Scobie, Susie</creator><creator>Whelan, Ellena</creator><creator>Prada, Diana</creator><creator>Mercer, Andrew A</creator><creator>Duckworth, Janine A</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20110620</creationdate><title>Vaccinia virus as a vaccine delivery system for marsupial wildlife</title><author>Cross, Martin L ; Fleming, Stephen B ; Cowan, Phil E ; Scobie, Susie ; Whelan, Ellena ; Prada, Diana ; Mercer, Andrew A ; Duckworth, Janine A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-4a23910a8886f605ad4dc134f61a689129fece5a7a1ec9904041e17353ab3d103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Administration, Oral</topic><topic>Allergy and Immunology</topic><topic>Animal reproduction</topic><topic>Animals</topic><topic>Animals, Wild - virology</topic><topic>Antibodies, Helminth - blood</topic><topic>Antigens</topic><topic>Antigens, Helminth - genetics</topic><topic>Antigens, Helminth - immunology</topic><topic>Antigens, Helminth - metabolism</topic><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Disease</topic><topic>Disease control</topic><topic>Diseases caused by cestodes</topic><topic>Drug Delivery Systems - methods</topic><topic>Drug Delivery Systems - veterinary</topic><topic>Echinococcoses</topic><topic>Echinococcosis - immunology</topic><topic>Echinococcosis - prevention &amp; control</topic><topic>Echinococcus granulosus</topic><topic>Echinococcus granulosus - genetics</topic><topic>Echinococcus granulosus - immunology</topic><topic>Echinococcus granulosus - metabolism</topic><topic>Female</topic><topic>Fertility</topic><topic>Fertility-control</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic Vectors</topic><topic>Helminth Proteins - genetics</topic><topic>Helminth Proteins - immunology</topic><topic>Helminth Proteins - metabolism</topic><topic>Helminthic diseases</topic><topic>Hydatid disease</topic><topic>Immunization</topic><topic>Immunogenicity</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Introduced species</topic><topic>Livestock</topic><topic>Lymphocyte Activation</topic><topic>Lymphocytes</topic><topic>Mammals</topic><topic>Marsupial</topic><topic>Marsupials</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Oronasal vaccine</topic><topic>Parasitic diseases</topic><topic>Poxvirus</topic><topic>Reproductive system</topic><topic>Trichosurus - virology</topic><topic>Trichosurus vulpecula</topic><topic>Vaccines</topic><topic>Vaccines - administration &amp; dosage</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Vaccinia</topic><topic>Vaccinia virus</topic><topic>Vaccinia virus - genetics</topic><topic>Vaccinia virus - immunology</topic><topic>Vaccinia virus - pathogenicity</topic><topic>Virology</topic><topic>Wildlife</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cross, Martin L</creatorcontrib><creatorcontrib>Fleming, Stephen B</creatorcontrib><creatorcontrib>Cowan, Phil E</creatorcontrib><creatorcontrib>Scobie, Susie</creatorcontrib><creatorcontrib>Whelan, Ellena</creatorcontrib><creatorcontrib>Prada, Diana</creatorcontrib><creatorcontrib>Mercer, Andrew A</creatorcontrib><creatorcontrib>Duckworth, Janine A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cross, Martin L</au><au>Fleming, Stephen B</au><au>Cowan, Phil E</au><au>Scobie, Susie</au><au>Whelan, Ellena</au><au>Prada, Diana</au><au>Mercer, Andrew A</au><au>Duckworth, Janine A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccinia virus as a vaccine delivery system for marsupial wildlife</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2011-06-20</date><risdate>2011</risdate><volume>29</volume><issue>28</issue><spage>4537</spage><epage>4543</epage><pages>4537-4543</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract Vaccines based on recombinant poxviruses have proved successful in controlling diseases such as rabies and plague in wild eutherian mammals. They have also been trialled experimentally as delivery agents for fertility-control vaccines in rodents and foxes. In some countries, marsupial mammals represent a wildlife disease reservoir or a threat to conservation values but, as yet there has been no bespoke study of efficacy or immunogenicity of a poxvirus-based vaccine delivery system in a marsupial. Here, we report a study of the potential for vaccination using vaccinia virus in the Australian brushtail possum Trichosurus vulpecula , an introduced pest species in New Zealand. Parent-strain vaccinia virus (Lister) infected 8/8 possums following delivery of virus to the oral cavity and outer nares surfaces (oronasal immunisation), and persisted in the mucosal epithelium around the palatine tonsils for up to 2 weeks post-exposure. A recombinant vaccinia virus construct (VV399, which expresses the Eg95 antigen of the hydatid disease parasite Echinococcus granulosus ) was shown to infect 10/15 possums after a single-dose oronasal delivery and to also persist. Both parent vaccinia virus and the VV399 construct virus induced peripheral blood lymphocyte reactivity against viral antigens in possums, first apparent at 4 weeks post-exposure and still detectable at 4 months post-exposure. Serum antibody reactivity to Eg95 was recorded in 7/8 possums which received a single dose of the VV399 construct and 7/7 animals which received triple-dose delivery, with titre end-points in the latter case exceeding 1/4000 dilution. This study demonstrates that vaccinia virus will readily infect possums via a delivery means used to deploy wildlife vaccines, and in doing is capable of generating immune reactivity against viral and heterologous antigens. This highlights the future potential of recombinant vaccinia virus as a vaccine delivery system in marsupial wildlife.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>21570435</pmid><doi>10.1016/j.vaccine.2011.04.093</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2011-06, Vol.29 (28), p.4537-4543
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_874194191
source MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland
subjects Administration, Oral
Allergy and Immunology
Animal reproduction
Animals
Animals, Wild - virology
Antibodies, Helminth - blood
Antigens
Antigens, Helminth - genetics
Antigens, Helminth - immunology
Antigens, Helminth - metabolism
Applied microbiology
Biological and medical sciences
Disease
Disease control
Diseases caused by cestodes
Drug Delivery Systems - methods
Drug Delivery Systems - veterinary
Echinococcoses
Echinococcosis - immunology
Echinococcosis - prevention & control
Echinococcus granulosus
Echinococcus granulosus - genetics
Echinococcus granulosus - immunology
Echinococcus granulosus - metabolism
Female
Fertility
Fertility-control
Fundamental and applied biological sciences. Psychology
Genetic Vectors
Helminth Proteins - genetics
Helminth Proteins - immunology
Helminth Proteins - metabolism
Helminthic diseases
Hydatid disease
Immunization
Immunogenicity
Infections
Infectious diseases
Introduced species
Livestock
Lymphocyte Activation
Lymphocytes
Mammals
Marsupial
Marsupials
Medical sciences
Microbiology
Miscellaneous
Oronasal vaccine
Parasitic diseases
Poxvirus
Reproductive system
Trichosurus - virology
Trichosurus vulpecula
Vaccines
Vaccines - administration & dosage
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
Vaccinia
Vaccinia virus
Vaccinia virus - genetics
Vaccinia virus - immunology
Vaccinia virus - pathogenicity
Virology
Wildlife
title Vaccinia virus as a vaccine delivery system for marsupial wildlife
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T17%3A14%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccinia%20virus%20as%20a%20vaccine%20delivery%20system%20for%20marsupial%20wildlife&rft.jtitle=Vaccine&rft.au=Cross,%20Martin%20L&rft.date=2011-06-20&rft.volume=29&rft.issue=28&rft.spage=4537&rft.epage=4543&rft.pages=4537-4543&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2011.04.093&rft_dat=%3Cproquest_cross%3E874194191%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1618947600&rft_id=info:pmid/21570435&rft_els_id=S0264410X11006487&rfr_iscdi=true